Selank Research Guide: Anxiolytic Peptide, GABA Modulation, and Immune-Neurological Interface

By Justin Cartier

Explore our full guide to nootropic peptides for cognitive research to see how this compares.

Selank is a synthetic peptide, seven amino acids in a row, that researchers study for calm. It’s an anxiolytic, and it works mainly at the brain’s GABA-A receptors. The twist: in lab studies it doesn’t bring the heavy sedation or dependence that benzodiazepine drugs do.^[1]

This article is for research and educational use only. Selank is a research compound, not a medicine, and isn’t for human use.

It’s built from tuftsin, a natural peptide that supports the immune system. The Russian team behind it added a Pro-Gly-Pro tail to one end so the body breaks it down more slowly, the same stability trick used in Semax. That keeps the peptide active long enough for a nasal spray to do its job. What sets it apart is that it does several things at once. It acts on GABA-A receptors, it slows the breakdown of the body’s own opioid peptides, the enkephalins, and it shifts immune gene activity. This guide covers the mechanisms of action, what the rodent and clinical data show, how it compares with Semax and with benzodiazepines, and what to check when sourcing material.

What is Selank and what is it used for?

The sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro, and it was made at the Russian Academy of Sciences as both an immune helper and an anti-anxiety compound. Russia approves it for generalized anxiety, for asthenic syndrome (a mix of mental and physical fatigue), and as an add-on in some viral infections. Health Canada, the FDA, and the EMA do not. Its main studied use is easing anxiety without the sedation and dependence benzodiazepines carry. Its effect on the immune system is the second research area.

How does Selank work?

Start with GABA, the brain’s main calming signal. Vyunova and colleagues, in Protein and Peptide Letters, peg it as a positive allosteric modulator at the GABA-A receptor.^[1] Plain English: it helps GABA work better instead of prying the receptor open itself. That one distinction is the whole story. Benzodiazepines crank GABA hard across every receptor type, and they pay for it in sedation. This peptide is fussier about where it acts. So the heavy sedation and the muscle weakness just don’t follow.

Route two is sneakier. It guards the enkephalins, the body’s own opioid-like peptides. Zozulya’s team, in the Bulletin of Experimental Biology and Medicine, caught it slowing the enzymes that chew those enkephalins up, which lifts natural opioid signaling without a single opioid drug in the mix.^[2] Stack that on top of the GABA support, and the calm it produces just reads differently from anything built around serotonin or dopamine.

The third effect is a slow burn, and it shows up in gene activity over days rather than minutes. Volkova and colleagues, reporting in Frontiers in Pharmacology, watched it shift the activity of GABA-signaling genes in the rat brain across 7 to 14 days of dosing.^[3] That slow rewiring might be the reason the calm outlasts the peptide’s actual time on the receptors.

Selank and the immune system

The immune link is the genuinely unusual part. Ershov and colleagues, in Problems of Virology, reported it raising the gene activity of interferon-alpha, a key immune signal, in the spleen and other immune tissue in animals.^[4] That’s a leftover from tuftsin, the immune peptide it was built from. Carrying both an anti-anxiety and an immune effect is rare among research peptides, which is exactly what makes it a handy tool for studying how stress and the immune system talk to each other across the nervous system.

Anti-fatigue and mild stimulant effects

There’s a lift to it, too, not just a calm. Zozulya’s 2008 clinical report in the Korsakov Journal of Neurology and Psychiatry describes anti-fatigue and mild stimulant effects riding alongside the anti-anxiety action.^[5] In Russian use, people describe better attention, less mental tiredness, and more mental clarity coming with the calm. That blend is part of why it gets studied for attention and anxiety-linked thinking problems, and why some group it loosely with the nootropic peptides.

Benefits of Selank

The benefits in rodent and Russian clinical studies line up into a recognizable picture. The calm arrives without sedation, motor trouble, or fog. People with asthenic syndrome focus better and tire less. Sleep improves, minus the next-day grogginess. Healthy adults post small cognitive gains, and that interferon-alpha bump throws in a little immune support on the side. Over weeks, baseline anxiety drifts down. Two things are worth underlining. It kicks in faster than an SSRI, hours to days instead of weeks. And quitting looks clean, with no rebound anxiety and no withdrawal anywhere in the literature.

Is Selank addictive?

Nothing in the published research points that way. Three decades of Russian use haven’t turned up dependence, tolerance, or withdrawal. Because its effect on GABA-A receptors is selective rather than the broad activation benzodiazepines cause, it skips the mechanism that drives benzo dependence. You can stop it abruptly without rebound anxiety. That, more than anything, is why researchers study it as a long-term alternative to benzodiazepines.

Selank vs benzodiazepines

Both ease anxiety through GABA-A receptors, but the how and the cost diverge sharply. Benzodiazepines like alprazolam, lorazepam, and diazepam bind one site and boost GABA hard across all receptor types. Selank works at a different site with a more selective touch. That difference shows up in the side effects: benzodiazepines bring sedation, motor and thinking problems, and dependence over long use, while the peptide doesn’t, at least not in published research. Benzodiazepines also light up standard drug tests; the peptide doesn’t. The honest trade-off is evidence and punch. Benzodiazepines have decades of clinical data and approval behind them and simply work better for sudden, intense anxiety, like a panic attack or pre-surgery nerves. For long-term, mild-to-moderate anxiety where dodging dependence is the priority, Selank is the research-tool alternative.

Selank vs Semax: which is better for anxiety?

For anxiety, Selank wins. For focus, Semax does. They’re sister peptides from the same Russian lab, aimed at different targets: one mainly calms anxiety through GABA, the other mainly sharpens thinking through BDNF and dopamine. Plenty of researchers run them together, leaning on Semax for daytime focus and Selank for managing stress.

Why is Selank not FDA approved?

The short answer is business, not safety. It’s approved in Russia but was never submitted to the FDA or Health Canada. The Russian Academy of Sciences holds the rights and hasn’t filed abroad. Full approval would mean running Phase 1, 2, and 3 trials to US and EU standards, plus a sponsor willing to spend the hundreds of millions that takes, and no such sponsor has stepped up. So the missing approval is a money-and-paperwork gap, not evidence of a safety or effectiveness problem.

Should you take Selank every day?

In Russian practice it’s usually given daily over weeks to months for anxiety and fatigue. Since it doesn’t drive dependence or tolerance, daily dosing is workable. Research protocols, though, often run 1-to-4-week cycles rather than nonstop dosing, so scientists can study dose effects and washout cleanly.

Dosage and routes of administration

The main Russian form is a nasal spray, a 0.15 percent solution. A typical approved dose is 300 micrograms per nostril, two to three times a day. Research protocols also use injection under the skin or into muscle. The calming effect starts within hours, while the longer-term drop in baseline anxiety builds over 2 to 4 weeks of steady use.

Is Selank safe? Side effects

After three decades of Russian use, the reported adverse effects are minimal: mild nose irritation from the spray, the rare brief headache, and occasional mild stomach upset with injections. No liver, heart, or whole-body safety problems have shown up. Within approved dose ranges, it’s regarded as safe.

Is Selank legal in the US?

It’s legal in the United States and Canada as a research chemical sold for laboratory research only. It isn’t approved as a finished medicine, and it isn’t on the World Anti-Doping Agency banned list.

Before you source it, it helps to know the legal framework for buying research peptides in Canada and how to vet a supplier.

Checking purity and handling at receipt

Confirm purity the moment the vial arrives, before you store or reconstitute it. Selank ships as a lyophilized (freeze-dried) white powder, so start with the batch-specific Certificate of Analysis (COA) from an independent lab: check that the identity and mass match the seven-amino-acid sequence near 752 Da, and that HPLC purity is 98 percent or higher with the chromatogram attached.^[6] For cell-culture or in-vivo work, look for endotoxin and sterility testing too. Once the COA checks out, keep the sealed powder cold and dry. A verified lyophilized peptide stays stable that way, and you only mix it with bacteriostatic water right before use.^[7]

Reviv Peptides supplies research-grade Selank with a third-party COA and HPLC purity confirmation. View the Selank 11mg product page.

Selank questions

What are the benefits of Selank?

Calm without sedation or dependence, better attention, less mental fatigue, better sleep, a rise in interferon-alpha that supports immune function, and lower baseline anxiety with longer-term dosing.

Why is Selank not FDA approved?

The Russian Academy of Sciences holds the rights and hasn’t filed with the FDA or Health Canada. The lack of approval is a money and paperwork issue, not proof of a safety or effectiveness problem.

Which is better for anxiety, Semax or Selank?

Selank is better for anxiety, through GABA support and enkephalin protection. Semax is better for focus and thinking, through BDNF and dopamine. Researchers often pair them, using Semax for activation and Selank for stress.

Is Selank addictive?

No dependence, tolerance, or withdrawal has been documented across three decades of Russian use. Its selective GABA effect avoids the broad receptor activation that drives benzodiazepine dependence.

How does Selank compare to benzodiazepines?

Both work on GABA-A receptors, but at different sites and with different results. Benzodiazepines bring sedation, motor problems, and dependence over long use; Selank doesn’t. Benzodiazepines work better for sudden, intense anxiety, while Selank fits long-term mild-to-moderate anxiety research.

Key data point: Russian clinical work reported the peptide’s calming effect was comparable to a benzodiazepine in generalized anxiety patients, with no sedation, no muscle relaxation, and no withdrawal after 4 weeks of use.^[5]

Summary

Selank is a Russian-developed synthetic peptide, a tuftsin analog, with an unusual double profile. It eases anxiety by supporting GABA-A receptors without driving dependence, and it raises interferon-alpha to lend the immune system a hand. Russia approves it for generalized anxiety and fatigue syndromes; in Canada and the United States it sells as a research chemical for laboratory research only. The non-sedating, non-addictive calm is its signature, and the bridge it forms between brain and immune systems makes it a genuinely useful research tool. It isn’t FDA approved, but that traces back to business reasons, not safety concerns.

Sources: [1] Selank as a GABA-A positive allosteric modulator, PubMed. [2] Selank inhibits enkephalin-degrading enzymes, PubMed. [3] Selank affects GABAergic gene expression, PubMed. [4] Selank and interferon / antiviral activity, PubMed. [5] Selank in anxiety and asthenia (anti-fatigue effects), PubMed. [6] Reference standards for synthetic peptide quality (HPLC/MS purity), PMC. [7] Storage and handling of peptides, PMC.

Justin Cartier

The Reviv Peptides Research Team is a collective of science writers and researchers dedicated to producing evidence-based, peer-reviewed-grade content about research peptides. Our work focuses on molecular mechanisms, receptor pharmacology, and preclinical data — including GLP-1/GIP/glucagon incretin biology, growth hormone axis peptides (GHRH analogs and ghrelin-receptor secretagogues), mitochondrial-derived peptides (MOTS-c, SS-31), tissue-repair peptides (BPC-157, TB-500, GHK-Cu), and nootropic peptides (Semax, Selank). All content is written in a strict preclinical/laboratory context; none of our editorial material is intended as medical advice. Every guide is reviewed for scientific accuracy against published peer-reviewed literature.